×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 11 Track 2B: Personalized Medicine: Gene Therapy
Session Chair(s)
Eileen Girten, MS
Director, Medical Writing
Pfizer Inc, United States
You will leave this session with a basic understanding of what gene therapy is, how gene therapy works, and the challenges associated with education and awareness in the gene therapy space.
Learning Objective : At the conclusion of this session, participants should be able to:- Differentiate between basic types of gene therapy
- Explain how gene therapy works using simple terms
- Describe the key challenges associated with educating audiences about gene therapy
- Identify key insights regarding the straightforward communication of complex science
Speaker(s)
AAV Gene Therapies for Rare Diseases
Kendra Bolt, PhD
Audentes Therapeutics, United States
Senior Manager of Scientific Communications